Financial highlights for Quarter ended December 31, 2014 (Q5 FY15) - Standalone Revenue of Rs 164.54 crore (US$ 26.1 million) in the quarter ended December 31, 2014 (Q5 FY14) as compared to Rs 371.60 crore (US$ 58.9 million) registered during the ... 4 Traders, 2 months ago
2 images for "orchid chemicals and pharmaceuticals ltd"
Related to : Sun Pharma Advanced Research Company Ltd,Strides Arcolab Ltd,Natco Pharma Ltd,Ajanta Pharma Ltd Sun Pharma Advanced Research Company Ltd BSE 20 Mar 15 | 03:28 PM 470.70 -69.45 (-12.86%) NSE 20 Mar 15 | 03:20 PM 472.80 ...Smart Investor, 1 month ago
/PRNewswire/ -- Report Details Generic Drugs - new study showing you trends, R&D progress, and predicted revenues Where is the market for generic drugs heading? What are the commercial prospects for this market and related technologies? ...Tamar Securities, 2 weeks ago
Yellen faces Senate grilling on Fed rate policy, transparency ( Reuters ) Big Banks Face Scrutiny Over Pricing of Metals ( WSJ ) Greece makes more concessions to euro zone, Germany sets vote ( Reuters ) Time for another executive order: Longer ...Zero Hedge, 2 months ago
The Q4 earnings season has effectively come to an end for most of the major sectors, with the Retail sector as the only one that has a significant number of reports still awaited. It has been a lackluster reporting season in the aggregate, with a ...Zacks.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!